The DOI matches its Crossref record.
Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors
Open accessAbstract
In order to compare in vivo metabolism between malignant gliomas and normal brain, (13)C magnetic resonance (MR) spectroscopic imaging data were acquired from rats with human glioblastoma xenografts (U-251 MG and U-87 MG) and normal rats, following injection of hyperpolarized [1-(13)C]-pyruvate. The median signal-to-noise ratio (SNR) of lactate, pyruvate, and total observed carbon-13 resonances, as well as their relative ratios, were calculated from voxels containing Gadolinium-enhanced tissue in T(1) postcontrast images for rats with tumors and from normal brain tissue for control rats. [1-(13)C]-labeled pyruvate and its metabolic product, [1-(13)C]-lactate, demonstrated significantly higher SNR in the tumor compared with normal brain tissue. Statistical tests showed significant differences in all parameters (P < .0004) between the malignant glioma tissue and normal brain. The SNR of lactate, pyruvate, and total carbon was observed to be different between the U-251 MG and U-87 MG models, which is consistent with inherent differences in the molecular characteristics of these tumors. These results suggest that hyperpolarized MR metabolic imaging may be valuable for assessing prognosis and monitoring response to therapy for patients with brain tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lactate: A Metabolic Key Player in Cancer
Hirschhaeuser, F., Sattler, U. G. A., & Mueller-Klieser, W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1457 · Cited by 1,090
Kurhanewicz, J., Vigneron, D. B., Brindle, K., Chekmenev, E. Y., Comment, A., Cunningham, C. H., DeBerardinis, R. J., Green, G. G., Leach, M. O., Rajan, S. S., et al. (2011) · Neoplasia · doi:10.1593/neo.101102 · Cited by 681
Self-citationStacpoole, P. W. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx071 · Cited by 402
Hyperpolarized 13C MRI: State of the Art and Future Directions
Wang, Z. J., Ohliger, M. A., Larson, P. E. Z., Gordon, J. W., Bok, R. A., Slater, J., Villanueva-Meyer, J. E., Hess, C. P., Kurhanewicz, J., & Vigneron, D. B. (2019) · Radiology · doi:10.1148/radiol.2019182391 · Cited by 337
Self-citationHypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
Marchiq, I., & Pouysségur, J. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1307-x · Cited by 300
“Furthermore, high lactate levels were described, as a potential marker of human rectal adenocarcinoma [11], glioblastoma [88, 89] and prostate tumour aggressiveness [90, 91], as far as it is positively associated with resistance to radiation and probability of metastasis.”
Background
Metadata
- Authors
- Park, I., Larson, P. E. Z., Zierhut, M. L., Hu, S., Bok, R., Ozawa, T., Kurhanewicz, J., Vigneron, D. B., VandenBerg, S. R., James, C. D., & Nelson, S. J.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-01-25
- Volume
- 12
- Issue
- 2
- Pages
- 133-144
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2160085140
- Cited by
- 192
- References
- 0
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. https://app.cochat.ai/papers/10.1093/neuonc/nop043
- The paper
- Park, I., Larson, P. E. Z., Zierhut, M. L., Hu, S., Bok, R., Ozawa, T., Kurhanewicz, J., Vigneron, D. B., VandenBerg, S. R., James, C. D., & Nelson, S. J. (2010). Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro-Oncology. https://doi.org/10.1093/neuonc/nop043
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.